Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Clinical Study to Evaluate the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen on Healthy Female Subjects.

Authors not listed

Revision Skincare · 2024

Dysbiosis Human Randomized controlled trial

Abstract

A12-week single-center, open-label, clinical study is being conducted to assess the efficacy and tolerability of the Brightening Treatment paired with a skincare regimen on healthy female subjects aged 20-65 years with Fitzpatrick Skin Types I - VI and moderate global facial pigmentation due to sun exposure, blemishes, and/or procedures when applied by a clinician in a series of 4 sessions at 2-week intervals. The procedure in this clinical study will include the brightening treatment, retinol serum, and a post-procedure cream. The study visits include baseline, week 2, 6, and 12.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-06 MST

Cite this

APA

Anonymous. (2024). A Clinical Study to Evaluate the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen on Healthy Female Subjects. <em>Revision Skincare</em>. https://clinicaltrials.gov/study/NCT07501000

Vancouver

Anonymous. A Clinical Study to Evaluate the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen on Healthy Female Subjects. Revision Skincare. 2024.

BibTeX

@misc{anon2024AClini, title = {A Clinical Study to Evaluate the Safety and Tolerability of a Brightening Treatment Paired With a Skincare Regimen on Healthy Female Subjects.}, author = {Anonymous}, journal = {Revision Skincare}, year = {2024}, }